Chloe Ahmann, assistant professor of anthropology in the College of Arts and Sciences, is helping local organizers in their quest for environmental justice — and bringing her students along. For this work, Ahmann was named recipient of this year’s Kaplan Family Distinguished Faculty Fellowship.
A new study from Weill Cornell Medicine provides insights into how cells maintain the tiny end caps of chromosomes as they divide, a key process in keeping cells healthy.
Weill Cornell Medicine has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer.
Faculty from the Department of Public & Ecosystem Health in the Cornell University College of Veterinary Medicine, in partnership with the University of Pretoria in South Africa, have received an NIH P20 grant to establish the Center for Transformative Infectious Disease Research on Climate, Health and Equity in a Changing Environment (C-CHANGE).
In November, mmore than 500 stakeholders gathered at the OnCenter in Syracuse for the 2024 New York Far to School Summit, cohosted by Cornell Cooperative Extension's Harvest New York team.
The overwhelming majority of those in New York City who obtained a naloxone kit to counteract opioid overdose had a high need for the drug, according to a new study by Weill Cornell Medicine investigators.
A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment.
Cornell researchers found that by prioritizing the perspectives of white Americans instead of those from underrepresented groups, studies of pandemic disparities likely missed important insights from those most affected by COVID-19.
A person’s “bioenergetic age” – or how youthfully their cells generate energy – might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.
Researchers have pinpointed a key enzyme that allows Legionella to persist in the environment and in the body - and which could be used as a target for treatment for Legionnaires' disease.